GlassScriptPhysician profile
Kashif Yaqub
NPI 1124348479
$4,155.99
in general payments reported to CMS, 2019-2025
22 companies · $545 in 2025
The $545 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,501 · 2023: $1,155 · 2024: $956 · 2025: $545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,638 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,638.03 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $919.23 | 2022-2025 | Fasenra, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $761.81 | 2022-2025 | Trelegy Ellipta, Nucala |
| Mylan Specialty L.P. | $508.35 | 2022-2024 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $371.26 | 2022-2023 | Ofev |
| Takeda Pharmaceuticals U.S.A., INC. | $338.39 | 2022-2024 | Hyqvia, Cuvitru |
| Amgen INC. | $177.25 | 2022-2024 | Tezspire |
| Regeneron Healthcare Solutions, INC. | $177.05 | 2022-2024 | Dupixent |
| Grifols USA, LLC | $166.37 | 2022-2024 | Prolastin-C Liquid |
| Baxter Healthcare | $115.51 | 2022-2024 | Hillrom - Vest System Model 105 Home Care |
| Insmed, INC. | $113.86 | 2023-2025 | Arikayce, Brinsupri |
| Paratek Pharmaceuticals, INC. | $94.92 | 2023-2025 | Nuzyra |
| United Therapeutics Corporation | $64.09 | 2022-2023 | Tyvaso |
| Verona Pharma, INC. | $58.48 | 2025 | Ohtuvayre |
| Viatris Specialty LLC | $54.10 | 2025 | Yupelri |
| Genentech USA, INC. | $48.95 | 2022-2023 | Xolair |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $36.52 | 2022-2023 | Smartvest |
| Philips North America LLC | $34.93 | 2024 | (Ak6) Vest Therapy |
| Harmony Biosciences LLC | $29.30 | 2022 | |
| Vifor Pharma, INC. | $27.72 | 2024 | Zemaira |
| Sanofi Pasteur INC. | $22.07 | 2023 | |
| Pfizer INC. | $20.13 | 2022 | |
| Merck Sharp & Dohme LLC | $15.70 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kashif Yaqub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.